Results 141 to 150 of about 18,591,271 (238)
New psychoactive substances (designer drugs): an approach to classification
BACKGROUND: Substance use disorders remain a global public health problem. In recent decades, the drug market has undergone substantial changes, with traditional drugs increasingly replaced by new psychoactive substances characterized by high toxicity ...
Mars A. Sary +6 more
core +1 more source
Abstract Although attentional bias toward sleep‐related stimuli is well documented in insomnia and is regarded as a cognitive outcome arising after the disorder's onset, it remains unclear whether insomnia also involves a general negative attentional bias toward nonsleep negative stimuli, a transdiagnostic vulnerability for psychiatric disorders ...
Liping Hu +5 more
wiley +1 more source
ABSTRACT Objective Obstructive sleep apnea (OSA) is associated with neurocognitive impairment, but its causal relationship with personality traits remains poorly understood. This study investigates the association and causality between OSA and personality using both cohort and genetic data.
Jian‐Hong Liao +4 more
wiley +1 more source
New psychoactive substances in Australia
Over the past decade, countries worldwide have observed the rapid emergence of substances collectively referred to as ‘new psychoactive substances’ (NPS). To date, hundreds of NPS have been identified; however, for the most part very little is known about these substances.
openaire +2 more sources
Policy Points The liberalization of medical and recreational cannabis policies may increase cannabis initiation across age groups, with increased prevalence of cannabis use among young adults and adults and weaker effects among youth. Evidence also suggests increases in cannabis‐related health care utilization among adults.
SARAH B. WINDLE +8 more
wiley +1 more source
ABSTRACT Objective To investigate whether lithium exposure in pregnancy is associated with spontaneous preterm birth, congenital malformations and abnormal fetal growth. Design Statewide retrospective cohort study. Setting Victoria, Australia. Population 867 454 births (2009–2020), including 234 (0.03%) exposed to lithium during pregnancy.
Alexandra Roddy Mitchell +10 more
wiley +1 more source
New Psychoactive Substances: Risks and Challenges
New psychoactive substances (NPS) have emerged in the last few years in response to market trends and legislative control. Only in the EU, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) reported in its European Drug Report 2016 the ...
Soria Sanchez Ma. Luisa
core
Abstract Novel psychoactive substances (NPS) are compounds emerging as alternatives to more established drugs of abuse. They are constantly changing and being modified, which makes their detection difficult. The study objective was to determine the prevalence of NPS in selected clinical specimens. Deidentified urine specimen remnants were analyzed that
Jillian R. Neifeld +2 more
wiley +1 more source
Protodesnitazene: The identification and tissue distribution of a new nitazene
Abstract Multiple new analogues from the 2‐benzyl benzimidazole or “nitazene” class of drugs have emerged on the drug market in recent years. Nitazenes are highly potent μ‐opioid receptor agonists that present a substantial public health concern due to their elevated risk of severe toxicity in overdose and their significant potential for misuse.
Andrew Griffiths +4 more
wiley +1 more source

